Börgermann J, Friedrich I, Scheubel R, Kuss O, Lendemans S, Silber R-E, Kreuzfelder E, Flohé S
Cardiac and Thoracic Surgery, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Thorac Cardiovasc Surg. 2007 Feb;55(1):24-31. doi: 10.1055/s-2006-924621.
Cardiopulmonary bypass (CPB) is associated with a disturbed immune response, e.g., impaired HLA-DR expression on monocytes and the release of pro- and anti-inflammatory cytokines. Cytokine release plays a role in the pathogenesis of postoperative systemic inflammatory response syndrome (SIRS) and immune system deterioration, e.g., impaired monocyte and polymorphonuclear neutrophil (PMN) function, factors that ultimately lead to an increased susceptibility to infections. To gain a further understanding, we investigated HLA-DR expression on monocytes and on B- and T-lymphocytes. In addition, we investigated the IN VITRO effect of the immunostimulating hematopoietic growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF) on HLA-DR expression of these cell types. Neither HLA-DR expression on B- and T-lymphocytes nor the effects of GM-CSF in cardiac surgical patients have been studied before.
In 16 patients undergoing elective cardiac surgery with CPB, counts of circulating leukocyte subsets as well as HLA-DR expression on monocytes, B- and T-lymphocytes were measured by flow cytometry before, immediately after CPB, and on the 2nd and 10th postoperative days. Treatment with GM-CSF was performed IN VITRO in whole blood cultures with 100 ng/ml recombinant human GM-CSF for 20 h.
Monocyte HLA-DR expression was attenuated immediately after CPB (125 +/- 4 mean channel fluorescence [MCF] vs. 143 +/- 2 MCF preoperatively, mean +/- SEM, P < 0.001). HLA-DR expression further decreased on the 2nd day after CPB and did not normalize until the 10th day after the operation. In contrast, HLA-DR expression on T-cells was unchanged, whereas HLA-DR expression on B-cells did not decrease before the 2nd day after CPB (152 +/- 3 MCF vs. 170 +/- 2 MCF preoperatively, P < 0.001). IN VITRO GM-CSF treatment increased HLA-DR expression on monocytes prepared after CPB to a degree comparable to preoperative values. HLA-DR expression on B-lymphocytes could not be restored by GM-CSF.
Immune system suppression after cardiac surgery is reflected in prolonged diminished HLA-DR expression on monocytes and B-lymphocytes. Suppression is not irreversible but can - at least IN VITRO - be overridden by the immunostimulating compound GM-CSF.
体外循环(CPB)与免疫反应紊乱相关,例如单核细胞上HLA-DR表达受损以及促炎和抗炎细胞因子的释放。细胞因子释放参与术后全身炎症反应综合征(SIRS)的发病机制和免疫系统恶化过程,例如单核细胞和多形核中性粒细胞(PMN)功能受损,这些因素最终导致感染易感性增加。为了进一步了解,我们研究了单核细胞以及B淋巴细胞和T淋巴细胞上的HLA-DR表达。此外,我们研究了免疫刺激造血生长因子粒细胞-巨噬细胞集落刺激因子(GM-CSF)对这些细胞类型HLA-DR表达的体外作用。此前尚未研究过心脏手术患者B淋巴细胞和T淋巴细胞上的HLA-DR表达以及GM-CSF的作用。
对16例行择期心脏手术并使用CPB的患者,在CPB前、CPB后即刻、术后第2天和第10天,通过流式细胞术检测循环白细胞亚群计数以及单核细胞、B淋巴细胞和T淋巴细胞上的HLA-DR表达。在含有100 ng/ml重组人GM-CSF的全血培养物中进行体外GM-CSF处理20小时。
CPB后即刻单核细胞HLA-DR表达减弱(平均通道荧光[MCF]为125±4,术前为143±2,平均值±标准误,P<0.001)。CPB后第2天HLA-DR表达进一步降低,直到术后第10天才恢复正常。相比之下,T细胞上的HLA-DR表达未改变,而CPB后第2天之前B细胞上的HLA-DR表达未降低(术前MCF为170±2,术后为152±3,P<0.001)。体外GM-CSF处理使CPB后制备的单核细胞上的HLA-DR表达增加到与术前值相当的程度。GM-CSF无法恢复B淋巴细胞上的HLA-DR表达。
心脏手术后免疫系统抑制表现为单核细胞和B淋巴细胞上HLA-DR表达长期降低。这种抑制并非不可逆转,至少在体外可被免疫刺激化合物GM-CSF克服。